Case (I) Chemosensitive group. (a) Indistinct margined, oval shaped, hyperdense mass in Rt. UIQ with clustered pleomorphic microcalcifications (b) Nearly.

Slides:

Advertisements

Similar presentations

Golan.O, Sperber.F, Shalmon.A, Weinstein.I, Gat.A

Advertisements

بسم الله الرحمن الرحيم.

Z. OUERGHI; N. DALI; A. MANAMANI A; A. BEN TEKAYA; I. MARZOUK; L

COMPUTATIONAL INTELLIGENCE FOR THE DETECTION AND CLASSIFICATION OF MALIGNANT LESIONS IN SCREENING MAMMOGRAPHY DATA E. Panourgias,

Slide Seminar Sami Shousha, MD, FRCPath Department of Histopathology, Charing Cross Hospital & Imperial College, London Amman, November 2013.

MCQs On Breast Imaging:

Case presentation DR.AHMED KENSARAH.

Breast Neoplasm In this section we will be discussing breast neoplasm.

AJCC TNM Staging 7th Edition Breast Case #3

AJCC Staging Moments AJCC TNM Staging 7th Edition Breast Case #2 Contributors: Stephen B. Edge, MD Roswell Park Cancer Institute, Buffalo, New York David.

Breast Cancer Clinical Cases Daniel A. Nikcevich, MD, PhD SMDC Cancer Center April 20, 2009.

BI-RADS By Nina Zahedi MD.

Marion C.W. Henry, MD Yale University

AJCC Staging Moments AJCC TNM Staging 7th Edition Breast Case #1 Contributors: Stephen B. Edge, MD Roswell Park Cancer Institute, Buffalo, New York David.

Breast Conference 9/7/2011.

Cancer Estimated US Cancer Cases Cancer Incidence Rates for Women, USA.

WORK UPS. Ultrasound method of choice for the differentiation of cysts from solid masses and for guidance in interventional procedures. Benign: – solid.

NYU Medical Grand Rounds Clinical Vignette Daniel P. Eiras, MD, MPH PGY2 December 1, 2010 U NITED S TATES D EPARTMENT OF V ETERANS A FFAIRS.

Case 48 y.o. healthy woman Right breast mass present for 4 weeks No other known health problems Clinical breast examination: –Fullness visible in R breast.

The Breast Clinic Index case Year 2 Michaelmas term.

Radiologic Features of Idiopathic Granulomatous Mastitis Z. ACHOUR 1, H. EL MHABRECH 1, A. KHELIFFI 1, E. BEN SALEM 1, A. HADDAD 2, CH. LOUSSAIF 3, C.

Breast Conference 7/13/2011. RC AAF presenting with abnormal mammogram.

Basic Course For Medical College Student Breast Imaging Basic Course For Medical College Student WANG Deng-bin MD,Ph.D Dept. of Radiology,RuiJin Hospital.

The endless fight against breast cancer Department of Hemato-Oncology R2 최인아 / Prof 김시영.

Figure 1: a 32-year-old woman presented with RT breast mass, MRI showed false positive diagnosis of cancer. Dynamic contrast enhanced MRI, axial subtraction.

Case (II) Chemoresistant group. Case 6. F/41 Rt. breast cancer, 3 cycle NAC for 2 months (a) Indistinct margined, irregular shaped, hyperdense mass in.

Case Discussion. Case #1 64 year-old postmenopausal, no PMHx Routine MMG: 2cm nodule in RUQ, with microcalcifications Biopsy: IDC grade 2 with areas of.

Controversy of lymph node management in breast cancer in 2017

Ari Brooks, MD Cancer Surgeon, Big Data End User

Case report and literature review: Metastatic lobular carcinoma of the breast an unusual presentation Rodrigo Arrangoiz, Pavlos Papavasiliou, Holly Dushkin,

Fig. 7. A 70-year-old woman with invasive lobular cancer involving right breast underwent breast MRI. (a, b) On axial breast MRI, segmental clumped nonmass.

Invasive Lobular Cancer of the Breast: A Pictorial Essay of Imaging Findings on Mammography, Sonography, and Magnetic Resonance Imaging Sarah L. Savaridas,

Dr Amit Gupta Associate Professor Dept Of Surgery

Ductal carcinoma in situ diagnosed at US-guided 14-gauge core-needle biopsy for breast mass: Preoperative predictors of invasive breast cancer Ah Young.

Example 7: (A,B) Diagnostic mammogram in 63-year-old woman who presented with a palpable mass in the left breast. CC and MLO views of the left breast shows.

Fig. 4. A 50-year-old woman with invasive ductal cancer involving left breast underwent breast MRI and PET-CT. (a, b) On axial breast MRI, irregular and.

Fig. 1. A 60-year-old woman with a palpable lump in right breast

Fig. 1. Luminal A type breast cancer of 37-year-old woman. A

Fig. 2. Triple negative type breast cancer of 37-year-old woman. A

Fig. 2. Mammography images of post radiation sarcoma

Ductal Carcinoma (Breast Cancer)

Challenge in Breast imaging: volumetric analysis of tumor/breast ratio

A case report of locally advanced triple negative breast cancer showing pathological complete response to weekly paclitaxel with bevacizumab treatment.

Case scenario- Breast Lump

Fig. 4. Follow-up abdominal computed tomography scans after six cycles of S-1/cisplatin combination chemotherapy (A, B) and 68 months after surgery (C,

Fig. 2. A 36-year-old woman underwent right breast-conserving surgery due to invasive ductal cancer seven months prior. A mediolateral oblique mammography.

Inflammatory Myofibroblastic Tumor of the Breast Coexisting with Breast Cancer: A Case Report Breast Care 2013;8: DOI: / Fig.

Fig. 1. Screening breast MR images of 31-year-old woman with personal history of contralateral breast cancer.Breast MRI was reported as negative finding.

Case scenario- Breast Lump

Contralateral axillary lymph node metastasis in second primary Breast cancer: Case report and review of the literature Jacob Gingerich, Edna Kapenhas,

Assessing neoadjuvant chemotherapy (NAC) response in patients with breast cancer using PEM and DCE-MRI: Pilot data Kirti Kulkarni MD, Daniel Appelbaum.

Fig. 2. Screening breast MR images of 46-year-old woman with personal history of contralateral breast cancer.Breast MRI was reported as multiple benign.

Fig. 1. Preoperative mammography and breast ultrasound of a 60-year-old woman. A. Mammography reveals a 0.9 cm mass (arrows) with an indistinct margin.

Thanh Nhan Hospital MALE BREAST CANCER: CASE REPORT

Mammogram images (A, B) indicate an irregular mass in the upper outer left breast. Ultrasound of the left breast (C) shows this to be a solid, hypoechoic.

Predict “invasive component” within ductal carcinoma in situ – the breast MRI features and clinicopathologic factors ? Hung-Wen Lai, MD, PhD1,4, Dar-Ren.

Metastatic Breast cancer

Mammography and Breast Localization for the Interventionalist

Current Status of Breast Ultrasound

Predicting Treatment Response of Breast Cancer to Neoadjuvant Chemotherapy Using Ultrasound-Guided Diffuse Optical Tomography Wenxiang Zhi, Guangyu Liu,

Axillary masses in a woman with a history of breast cancer: Dermatopathic lymphadenopathy Nicola Rocco, Gianni Antonio Della Corte, Corrado Rispoli,

Sonographic Features of Endobronchial Ultrasonography Predict Intrathoracic Lymph Node Metastasis in Lung Cancer Patients Lei Wang, MD, Weihua Wu, MD,

Mammography and Breast Localization for the Interventionalist

Avoiding Pitfalls in Mammographic Interpretation

Fig year-old woman with invasive ductal carcinoma of right breast

Marion C.W. Henry, MD Yale University

Fig. 9. A 56-year-old woman, who underwent chemotherapy due to advanced gastric cancer, complained of swelling and erythema of left breast. She underwent.

B A F/36, Rt. breast palpable mass : invasive ductal carcinoma, HER-2 (+) (A) Indistinct margined, oval shaped, hyperdense mass in Rt. UIQ on MG Combined.

Fig. 2. Korean Thyroid Imaging Reporting and Data System 5 (high suspicion). A. Solid hypoechoic nodule with microcalcifications. B. Solid hypoechoic nodule.

Predicting Axillary Response to Neoadjuvant Chemotherapy: Breast MRI and US in Patients with Node-Positive Breast Cancer An imaging-based predictive model.

Presentation transcript:

Case (I) Chemosensitive group

(a) Indistinct margined, oval shaped, hyperdense mass in Rt. UIQ with clustered pleomorphic microcalcifications (b) Nearly disappeared mass after NAC Case 1. F/36 Rt. breast cancer, 3 cycle NAC for 2 months ab

(c) Indistinct margined, oval shaped, complex echoic mass with parallel orientation in Rt. UIQ (d) Mass is decreased in size about 50% after NAC (4x2.1cm  2x0.6cm). c d

(e) Circumscribed, oval shaped, rim enhancing mass in Rt. UIQ on subtraction MRI (f) Mass is disappeared after NAC. * Confirmed as Invasive ductal carcinoma, HER-2 (+) * No residual tumor on final pathology after surgery ef

Case 2. F/48 Rt. breast cancer, 3 cycle NAC for 2 months (a) Obscured margined, oval shaped, hyperdense mass in Rt. UOQ Metastatic lymphadenopathy in Rt. axilla (b) Mass and lymphadenopathy are markedly decreased in size after NAC. ab

(c) Indistinct margined, oval shaped, hypoechoic mass with parallel orientation in Rt. UOQ (d) Mass is decreased in size about 75% after NAC (7.3x3.9 cm  1.8x1.3cm ). c d

(e) Irregular margined, oval shaped, rim enhancing mass in Rt. UOQ on subtraction MRI (f) Mass is marked decreased in size and enhancement after NAC (6cm  2.5cm). * Confirmed as Invasive ductal carcinoma, Triple (-) * Residual tumor size is 1.8cm on final pathology after surgery ef

Case 3. F/36 Rt. breast cancer, 3 cycle NAC for 2 months (a) Indistinct margined, oval shaped, isodense mass in Rt. UOQ with multiple axillary lymphadenopathies (b) Decreased in size of breast mass and axillary lymphadenopathies after NAC ab

(c) Angular margined, irregular shaped, hypoechoic mass with parallel orientation in Rt. UOQ (d) Enlarged hypoechoic lymph node in Rt. axilla (e) Mass is decreased in size about 34% after NAC (2.1x1.7  1.4x1.1cm) (f) Axillary lymph node is also decreased in size after NAC. c d ef

(g) Irregular margined, oval shaped, homogeneously enhancing mass in Rt. UOQ on subtraction MRI. (h) Mass is decreased in size about 31% after NAC (1.9cm  1.3cm). * Confirmed as Invasive ductal carcinoma, Triple (-) * Residual tumor size is 1.3cm on final pathology after surgery g h

Case 4. F/26 Rt. breast cancer, 6 cycle NAC for 4 months (a) Indistinct margined, irregular shaped, hypoechoic mass Rt. UOQ (b) Mass is markedly decreased in size (8.3x2.1 cm  1.6x0.9cm ) after 3 months, 4 cycles of NAC. ab

(c) Irregular margined, irregular shaped mass in Rt. UOQ on subtraction MRI (d) Mass is disappeared after 4 months, 6 cycles of NAC. * Confirmed as Invasive ductal carcinoma, Triple (-) * No residual tumor on final pathology after surgery c d

Case 5. F/35 Lt. breast cancer, 3 cycle NAC for 2 months (a) Indistinct margined, oval shaped, isodense mass in Lt. upper mid portion Metastatic lymphadenopathy in Lt. axilla (b) Mass and lymphadenopathy are markedly decreased in size after NAC. ab

(c) Indistinct margined, irregular shaped, hypoechoic mass with parallel orientation in Lt. upper mid portion (d) Mass is decreased in size about 63% after NAC (3x1.5cm  1.1x0.8cm). c d

* Confirmed as Invasive ductal carcinoma, ER (+) * Residual tumor size is 2.1cm on final pathology after surgery (e) Irregular margined, lobular shaped, heterogeneously enhancing mass in Lt. upper mid portion on subtraction MRI (f) Mass is marked decreased in size after NAC (4.1cm  2cm). ef